ライフサイエンスコーパス: catheter infection

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 enation cannula infection, and one pulmonary-catheter infection.

2 s with 5-fluorouracil may reduce the risk of catheter infection.

3 n thinking of strategies designed to prevent catheter infection.

4 al jugular accesses lead to similar risks of catheter infection.

5 s, in the treatment of S. aureus intravenous catheter infections.

6 Candida species are a major cause of catheter infections.

7 rapeutic interventions, and risk factors for catheter infections.

8 The incidence of catheter infection (4.01/1,000 catheter days, 2.29% cath

9 vely studied the incidence of central venous catheter infection and colonization at the subclavian, i

10 population, the incidence of central venous catheter infection and colonization is low overall and,

11 educed P. aeruginosa and other Gram-negative catheter infections and reduced peritonitis by 35%, part

12 ons included wound infections (62%), central catheter infections and/or bacteremia (16%), and possibl

13 f transplant recipients had life-threatening catheter infections, and 13 (65%) had a significant decr

14 oplasmosis infection; two Tenchkoff dialysis catheter infections; and fever (38.7 degrees C) during i

15 Central nervous system catheter infections are a serious complication in the tr

16 on site dressings are a major mean to reduce catheter infections by the extraluminal route.

17 0.5), multiple comorbidities, pneumonia and catheter infection, coexistent infection with antibiotic

18 In a mouse model of jugular vein catheter infection, dabigatran reduced bacterial load on

19 Sak also attenuated biofilm-associated catheter infections in mouse models.

20 aphylococcal and enterococcal central venous catheter infections in rats, and 24-hour postprophylaxis

21 The possibility that catheter infection is associated with gene polymorphisms

22 catheter-related thromboses include previous catheter infections, malposition of the catheter tip, an

23 ybrid biofilm both in vitro and in vivo in a catheter infection model.

24 ection when used in a CLS rat central venous catheter infection model.

25 achment of S. aureus biofilms in an in vitro catheter-infection model by using time-lapse microscopy.

26 Catheter-related thromboses can lead to catheter infection, pulmonary embolism, and post-thrombo

27 Catheter infection rates were 0.23/yr with gentamicin cr

28 Catheter infection rates were determined per 1,000 cathe

29 rmed biofilms and achieved cell densities in catheter infection studies that were equivalent to those

30 There were no P. aeruginosa catheter infections using gentamicin compared with 0.11/

31 Time to first catheter infection was longer using gentamicin (P = 0.03

32 The rate of catheter infection was not correlated with self-reported

33 /m2 as the maximum-tolerated dose (MTD), but catheter infection was the only significant complication

34 One hundred twenty-four central catheter infections were reported in 41 subjects (19 LD)

35 C. albicans biofilm-associated intravascular catheter infections, which warrants further study.

36 Catheter infection with E. cloacae occurred in 50% of ro

37 ive was to assess the risk of central venous catheter infection with respect to the site of insertion

38 Catheter infection with S. epidermidis occurred in 32% o

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。